William's Syndrome: Difference between revisions

No edit summary
No edit summary
Line 7: Line 7:
== Definition/Description  ==
== Definition/Description  ==


William’s Syndrome, also known as Williams-Beuren Syndrome was first recognized as a unique disorder in 1961.<ref name="1">Pober B, Johnson M, Urban Z. Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome. Journal of Clinical Investigation. (2008, May); 118(5): 1606-1615.</ref> J.C.P. Williams observed in four patients an association between supravalvular stenosis and the common physical and mental characteristics of this patient population and stated that it “may constitute a previously unrecognized syndrome”.<ref name="1" /> Later, A.J. Beuren described eleven new patients with the characteristics described by Williams and the disorder became known as Williams-Beuren Syndrome. Diagnosis of the syndrome can be made at birth based on physical characteristics, but a true medical diagnosis is confirmed following a diagnostic test called fluorescence in situ hybridization (FISH).1 The test reveals a recurring micro-deletion, with a size of 1,551,83 Mb, on chromosome band 7q11.23, which contains 24-28 genes.2-4 The deleted part of the chromosome band includes the elastin gene, which leads to serious cardiovascular complications.5<br>
William’s Syndrome, also known as Williams-Beuren Syndrome was first recognized as a unique disorder in 1961. J.C.P. Williams observed in four patients an association between supravalvular stenosis and the common physical and mental characteristics of this patient population and stated that it “may constitute a previously unrecognized syndrome”. Later, A.J. Beuren described eleven new patients with the characteristics described by Williams and the disorder became known as Williams-Beuren Syndrome. Diagnosis of the syndrome can be made at birth based on physical characteristics, but a true medical diagnosis is confirmed following a diagnostic test called fluorescence in situ hybridization (FISH).1 The test reveals a recurring micro-deletion, with a size of 1,551,83 Mb, on chromosome band 7q11.23, which contains 24-28 genes.2-4 The deleted part of the chromosome band includes the elastin gene, which leads to serious cardiovascular complications.5<br>


== Prevalence  ==
== Prevalence  ==

Revision as of 02:32, 5 April 2011

 

Welcome to PT 635 Pathophysiology of Complex Patient Problems This is a wiki created by and for the students in the School of Physical Therapy at Bellarmine University in Louisville KY. Please do not edit unless you are involved in this project, but please come back in the near future to check out new information!!

Original Editors - Julie Frederick from Bellarmine University's Pathophysiology of Complex Patient Problems project.

Lead Editors - Your name will be added here if you are a lead editor on this page.  Read more.

Definition/Description[edit | edit source]

William’s Syndrome, also known as Williams-Beuren Syndrome was first recognized as a unique disorder in 1961. J.C.P. Williams observed in four patients an association between supravalvular stenosis and the common physical and mental characteristics of this patient population and stated that it “may constitute a previously unrecognized syndrome”. Later, A.J. Beuren described eleven new patients with the characteristics described by Williams and the disorder became known as Williams-Beuren Syndrome. Diagnosis of the syndrome can be made at birth based on physical characteristics, but a true medical diagnosis is confirmed following a diagnostic test called fluorescence in situ hybridization (FISH).1 The test reveals a recurring micro-deletion, with a size of 1,551,83 Mb, on chromosome band 7q11.23, which contains 24-28 genes.2-4 The deleted part of the chromosome band includes the elastin gene, which leads to serious cardiovascular complications.5

Prevalence[edit | edit source]

Stated as being anywhere from 1/7,500 to 1/50,000.1,2,6,7 William’s Syndrome occurs sporadically and spontaneously and is found equally in all ethnicities, races, socioeconomic backgrounds and genders.1,5,7

Characteristics/Clinical Presentation[edit | edit source]

Common physical characteristics of children and adults with William's Syndrome1

• Craniofacial dysmorphic features1-5,7
o Full lips4,7, short nasal bridge4, large forehead4, long philthrum7, epicanthal folds7, hypertelorism7, mandibular hypoplasia7
• Mild to moderate mental retardation1-5,7
o Average IQ = 55-60 but can range from 40-901
• Mild to moderate learning disabilies2
• Associated systemic disorders (especially cardiovascular)1-7
• Mild growth retardation1,3, short stature5,7
• Commonly overweight as adults1
• Deficient visuo-spatial abilities3-5
• Global processing deficits4
• Overfriendly personalities2,3,5
• Very sociable4
• Hyperacusis or algiacusis3

Associated Co-morbidities[edit | edit source]

According to Pober, Johnson and Urban, all of the following conditions have been associated with William’s Syndrome1:

• Cardiovascular pathologies23456
o Supravalvular aortic stenosis46, hypertension45, ventricular septal defect6, patent ductus arteriosus6, stenosis of outlying arteries (renal, cerebral, carotid, coronary, brachiocephalic, subclavian, mesenteric, lung)6, arteriovenous shunt6, interruption of the aortic arch6, vein aplasia6, aortic aneurysm6, pulmonary arterial stenosis5, left and right ventricular hypertrophy5, aortic coarctation5, mitral valve prolapse5, aortic valvular insufficiency5
• Endocrine abnormalities5
o Hypercalcemia46, abnormal glucose metabolism, thyroid hypoplasia7, hypothyroidism7
• Dental anomalies
o Small, abnormally shape teeth, absent teeth, malocclusion
• Gastrointestinal
o Dysmotility, reflux, constipation, diverticular disease
• Musculoskeletal anomalies
o Joint stiffness, scoliosis
• Sensorineural hearing loss
• Genitourinay anomalies5
o Urinary frequency, bladder diverticuli
• Neurological problems
o Abnormal tone, hyperreflexia, cerebellar dysfunction

Medications[edit | edit source]

There are no medications for William’s Syndrome itself, however, common medications for systemic complications include: thyroxine for hypothyroidism7

Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]

The most common test used to diagnose William’s Syndrome is fluorescence in situ hybridization (FISH).1 Other tests to diagnose systemic complications include: electrocardiogram, ultrasonography, Tc-pertechnetate thyroid scinitgraphy, thyroid function tests,

Etiology/Causes[edit | edit source]

add text here

Systemic Involvement[edit | edit source]

add text here

Medical Management (current best evidence)[edit | edit source]

add text here

Physical Therapy Management (current best evidence)[edit | edit source]

add text here

Alternative/Holistic Management (current best evidence)[edit | edit source]

add text here

Differential Diagnosis[edit | edit source]

add text here

Case Reports/ Case Studies[edit | edit source]

add links to case studies here (case studies should be added on new pages using the case study template)

Resources
[edit | edit source]

www.williams-syndrome.org

kc.vanderbilt.edu

Recent Related Research (from Pubmed)[edit | edit source]

see tutorial on Adding PubMed Feed

Failed to load RSS feed from http://eutils.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1fs6_IKzbbn66yo2UkGTwcbuiUpkdih7ZpBSc29eNkFUNGbE-M|charset=UTF-8|short|max=10: Error parsing XML for RSS 


Failed to load RSS feed from http://eutils.ncbi.nlm.nih.gov/entrez/eutils/erss.cgi?rss_guid=1FomMFNkGLRuSnqZMhrqkezsNT-UPKoGv5ZFewx8TLPJubT9To|charset=UTF-8|short|max=10: Error parsing XML for RSS

References[edit | edit source]

1. Pober B, Johnson M, Urban Z. Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome. Journal of Clinical Investigation. (2008, May); 118(5): 1606-1615.
2. John A, Mervis C. Comprehension of the Communicative Intent Behind Pointing and Gazing Gestures by Young Children with Williams Syndrome or Down Syndrome. Journal of Speech, Language & Hearing Research. (2010, Aug); 53(4): 950-960.
3. Lucena J, Pezzi S, Aso E, Valero M, Carreiro C, Campuzano V, et al. Essential role of the N-terminal region of TFII-I in viability and behavior. BMC Medical Genetics. (2010, Apr 19); 1161.
4. Collette J, Xiao-Ning C, Mills D, Galaburda A, Reiss A, Korenberg J, et al. William's syndrome: gene expression is related to parental origin and regional coordinate control. Journal of Human Genetics. (2009, Apr); 54(4): 193-198.
5. Del Pasqua A, Rinelli G, Toscano A, Iacobelli R, Digilio C, de Zorzi A, et al. New Findings concerning Cardiovascular Manifestations emerging from Long-term Follow-up of 150 patients with the Williams-Beuren-Beuren syndrome. Cardiology in the Young. (2009, Dec); 19(6): 563-567.
6. Figueroa J, Olivares Rodríguez L, Pablos Hach J, Ruíz V, Martínez H. Cardiovascular Spectrum in Williams-Beuren Syndrome. Texas Heart Institute Journal. (2008, Sep); 35(3): 279-285.
7. Stagi, Manoni, Salti, Cecchi, Chiarelli. Thyroid Hypoplasia as a Cause of Congenital Hypothyroidism in Williams Syndrome. Hormone Research. (2008, Nov); 70(5): 316-318.

see adding references tutorial.